What: NIH to host Marijuana and Cannabinoids: A Neuroscience Research Summit, focusing on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be discussed.
Why: To ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana.
Who: The meeting is being sponsored by the National Institute on Drug Abuse (NIDA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Center for Complementary and Integrative Health (NCCIH); the National Institute of Mental Health (NIMH); and the National Institute of Neurological Disorders and Stroke (NINDS).
When: Tuesday, March 22, 2016
9:00 a.m. to 5:30 p.m. (Check-in begins at 8:00 a.m.)
Wednesday, March 23, 2016
9:00 a.m. to 4:00 p.m. (Check-in begins at 8:00 a.m.)
Where: Natcher Conference Center (Building 45)
National Institutes of Health Campus
9000 Rockville Pike
Bethesda, MD 20814
NOTE: Please allow additional time for check-in at security at the Gateway Center for the NIH Campus.
- Understanding the Endocannabinoid System
- Brain Development and Function
- Psychosis, Addiction, and Alcohol Interactions
- Psychomotor Performance and Detection
- Therapeutic Potential
- Policy-Related Research
Registration is free. To attend the Summit, please register by sending an email to firstname.lastname@example.org with your name and media outlet. Registered press will receive reserved seating and a press pass at the check-in table.
For those unable to attend, the Summit will be available via VideoCast. Please register for the VideoCast here: http://apps1.seiservices.com/nih/mj/2016/VideoCast.aspx
NOTE: Some data presented at the Summit may be embargoed. Please contact speakers directly for permission to use data.
For more information on the Summit, including the agenda, poster sessions and parking, transportation and security restrictions, go to: http://apps1.seiservices.com/nih/mj/2016/Default.aspx
Follow the Summit on Twitter at @NIDANews or join the conversation by using #MJNeuroSummit
NIDA is one of 27 Institutes within the National Institutes of Health.
NIDA Press Office: 301-443-6245; Media@nida.nih.gov
NIAAA Press Office: 301-443-3860; NIAAAPressOffice@mail.nih.gov
NCCIH Press Office: 301-496-7790; NCCIHpress@mail.nih.gov
NIMH Press Office: 301-443-4536; NIMHpress@nih.gov
NINDS Press Office: 301-496-5751; NINDSPressTeam@ninds.nih.gov
NIH Press Office: 301-496-5787; http://www.nih.gov/news-events/media-contacts
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit www.drugabuse.gov.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®